Cited by 106Lipoproteins and Cardiovascular HealthNatural Products and Biological ResearchCholesterol and Lipid Metabolism

Dietary Flaxseed Independently Lowers Circulating Cholesterol and Lowers It beyond the Effects of Cholesterol-Lowering Medications Alone in Patients with Peripheral Artery Disease1–4

Open access
Edel, Andrea L, Rodriguez-Leyva, Delfin, Maddaford, Thane G, Caligiuri, Stephanie PB, Austria, J Alejandro, Weighell, Wendy, Guzman, Randolph, Aliani, Michel +1 more·2015·The Journal of Nutrition

Abstract

Background Dietary flaxseed lowers cholesterol in healthy subjects with mild biomarkers of cardiovascular disease (CVD).Objective The aim was to investigate the effects of dietary flaxseed on plasma cholesterol in a patient population with clinically significant CVD and in those administered cholesterol-lowering medications (CLMs), primarily statins.Methods This double-blind, randomized, placebo-controlled trial examined the effects of a diet supplemented for 12 mo with foods that contained either 30 g of milled flaxseed [milled flaxseed treatment (FX) group; n = 58] or 30 g of whole wheat [placebo (PL) group; n = 52] in a patient population with peripheral artery disease (PAD). Plasma lipids were measured at 0, 1, 6, and 12 mo.Results Dietary flaxseed in PAD patients resulted in a 15% reduction in circulating LDL cholesterol as early as 1 mo into the trial (P = 0.05). The concentration in the FX group (2.1 ± 0.10 mmol/L) tended to be less than in the PL group (2.5 ± 0.2 mmol/L) at 6 mo (P = 0.12), but not at 12 mo (P = 0.33). Total cholesterol also tended to be lower in the FX group than in the PL group at 1 mo (11%, P = 0.05) and 6 mo (11%, P = 0.07), but not at 12 mo (P = 0.24). In a subgroup of patients taking flaxseed and CLM (n = 36), LDL-cholesterol concentrations were lowered by 8.5% ± 3.0% compared with baseline after 12 mo. This differed from the PL + CLM subgroup (n = 26), which increased by 3.0% ± 4.4% (P = 0.030) to a final concentration of 2.2 ± 0.1 mmol/L.Conclusions Milled flaxseed lowers total and LDL cholesterol in patients with PAD and has additional LDL-cholesterol-lowering capabilities when used in conjunction with CLMs. This trial was registered at clinicaltrials.gov as NCT00781950.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3945/jn.114.204594

Cites

51 of 51 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. Kauskot A, Hoylaerts M. Antiplatelet agents: platelet receptors. Gresele P, Born GVR, Patrono C, Page CP, editors. Berlin, Heidelberg: Springer- Verlag; 2012. p. 23-57.

Cited by

Sorted by citations

Authors
Edel, A. L., Rodriguez-Leyva, D., Maddaford, T. G., Caligiuri, S. P., Austria, J. A., Weighell, W., Guzman, R., Aliani, M., & Pierce, G. N.
Affiliations
St. Boniface Hospital (CA)
Corresponding author
  • Aliani, Michel
  • Pierce, Grant N
Venue
The Journal of Nutrition
Publisher
Elsevier BV
Published
2015-04
Volume
145
Issue
4
Pages
749-757
ISSN
0022-3166 (ISSN-L)
OpenAlex
W2120252198
Cited by
106
References
51
Citations by year
2026: 6 · 2025: 5 · 2024: 11 · 2023: 7 · 2022: 8 · 2021: 17 · 2020: 13 · 2019: 8 · 2018: 13 · 2017: 4 · 2016: 6 · 2015: 7
FWCI
10.10
Type
journal article
Language
en
Open access
Locations
  • Journal of Nutrition (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Flax2015, the Canola Council of Canada
  • Agri-Food Research and Development Initiative, and the Canadian Institutes for Health Research
  • Banting and Best Canada Graduate Scholarship Doctoral
  • Doctoral Research Scholarship from the Heart and Stroke Foundation of Canada
  • Patient-Oriented Research Doctoral Scholarship from CIHR
  • The Canadian International Grain Institute, Winnipeg, Manitoba, Canada
  • Food Development Center, Portage la Prairie, Manitoba, Canada
Topics
  • Health Sciences › Medicine › Surgery › Lipoproteins and Cardiovascular Health
  • Health Sciences › Medicine › Surgery › Natural Products and Biological Research
  • Health Sciences › Medicine › Surgery › Cholesterol and Lipid Metabolism
Keywords
flaxseed, dietary supplementation, LDL cholesterol, total cholesterol, peripheral arterial disease, cholesterol-lowering drugs, statins, whole wheat, plasma lipids, cardiovascular disease, omega-3 fatty acids, dietary fiber, polyunsaturated fatty acids, cardiovascular risk reduction, hypercholesterolemia, dyslipidemia, cardiovascular risk factors
MeSH terms
Adult, Anticholesteremic Agents, Diet, Double-Blind Method, Female, Humans, Cholesterol, HDL, Cholesterol, LDL, Male, Phytotherapy, Platelet Aggregation, Seeds, Triglycerides, Flax, Endpoint Determination, Plant Preparations, Peripheral Arterial Disease

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review